This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the hypothesis that that the product, Maitake-SX fraction, will decrease fasting blood glucose and improve glucose tolerance in patients with type 2 diabetes, without a significant impact on patients without diabetes.
Showing the most recent 10 out of 568 publications